Source:http://linkedlifedata.com/resource/pubmed/id/21502425
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-19
|
pubmed:abstractText |
Myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms are heterogeneous disorders. JAK2 mutation testing and karyotyping are routinely used for diagnosis but have not been incorporated into risk stratification in Philadelphia chromosome-negative myeloproliferative neoplasms. This study correlated cytogenetic abnormalities with disease stage and JAK2 status. A total of 179 cases were analyzed for the JAK2 mutation. Among them, cytogenetic data were available for 97 cases-45 of 106 JAK2+ and 52 of 73 JAK2-. The JAK2+ group showed a higher frequency of cytogenetic anomalies than the JAK2- group (23/45 [51%] vs 14/52 [27%]). Chromosome 9, chromosome 7, and 20q- were recurrent abnormalities in the JAK2+ group, whereas 13q- and trisomy 21 were common in the JAK2- group. In the JAK2+ group, chromosome 7 and complex cytogenetic abnormalities were associated with excess blasts/blastic transformation (P < .05), whereas no cases with 20q- underwent blastic transformation. Our results suggest that incorporation of JAK2 mutation testing and karyotyping allows for monitoring of disease progression with prognostic and therapeutic implications.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1943-7722
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
709-19
|
pubmed:meshHeading |
pubmed-meshheading:21502425-Cell Transformation, Neoplastic,
pubmed-meshheading:21502425-Chromosome Aberrations,
pubmed-meshheading:21502425-Chromosomes, Human, Pair 13,
pubmed-meshheading:21502425-Chromosomes, Human, Pair 20,
pubmed-meshheading:21502425-Chromosomes, Human, Pair 21,
pubmed-meshheading:21502425-Chromosomes, Human, Pair 7,
pubmed-meshheading:21502425-Chromosomes, Human, Pair 9,
pubmed-meshheading:21502425-Disease Progression,
pubmed-meshheading:21502425-Humans,
pubmed-meshheading:21502425-Janus Kinase 2,
pubmed-meshheading:21502425-Karyotyping,
pubmed-meshheading:21502425-Mutation,
pubmed-meshheading:21502425-Myelodysplastic-Myeloproliferative Diseases,
pubmed-meshheading:21502425-Myeloproliferative Disorders
|
pubmed:year |
2011
|
pubmed:articleTitle |
Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
|
pubmed:affiliation |
Department of Pathology, Oregon Health & Science University, Portland, USA.
|
pubmed:publicationType |
Journal Article
|